Nason Maani
@spidermaani.bsky.social
Senior Lecturer @ U of Ed GHPU, Dep Director @ UKPHI Local Health Global Profits, host @ MoneyPowerHealth, editor Commercial Determinants of Health (OUP), author of A Healthy Profit (OUP, 2026). Interested in commercial and social determinants of health
Reposted by Nason Maani
In @bmj.com, @spidermaani.bsky.social, @maizie333.bsky.social, and @markpetticrew.bsky.social highlight the £27.44bn annual cost of alcohol harms in England and the lack of transparency in the government’s licensing review.
November 13, 2025 at 10:42 AM
In @bmj.com, @spidermaani.bsky.social, @maizie333.bsky.social, and @markpetticrew.bsky.social highlight the £27.44bn annual cost of alcohol harms in England and the lack of transparency in the government’s licensing review.
Reposted by Nason Maani
You’ve probably seen this. Bottom line is that new meds tend to skew spend away from higher value interventions. www.thelancet.com/journals/lan...
Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000–20: a retrospective analysis
During 2000–20, NHS coverage of new drugs displaced more population health than it
generated. Our results highlight the inherent trade-offs between individuals who directly
benefit from new drugs and ...
www.thelancet.com
October 8, 2025 at 2:18 PM
You’ve probably seen this. Bottom line is that new meds tend to skew spend away from higher value interventions. www.thelancet.com/journals/lan...